These indications underline the prognostic value of our study and indicate that the assessment of LH level can help stratify the potential risks of adverse cardiac events in postmenopausal T2DM female patients to guide secondary preventive efforts.46 The gene discussed is PLOD1; the disease is type 2 diabetes mellitus.